Effects of zamic as a means for zinc supplementation in growing children.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

The researchers investigated the effects of zinc supplementation in case of moderate growth retardation in which GH treatment could not be used.

The researchers present preliminary results of 24 children who completed the study (3 girls, 21 boys, age 9-13 yr).

Who Took Part

The abstract describes 24 children taking part.

By PubMed's age tags, the people studied were children and teenagers, both men and women.

How the Study Was Run

The researchers set it up as a randomized, double-blind and crossover study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Blinding on both sides kept the children and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.

Each person switched between Vitamin D, K2, Magnesium and Zinc and the comparison at some point, usually with a gap in between.

What Was Measured

PubMed files the paper under topics including Arginine, Drug Combinations, Growth Disorders, Growth Hormone, Methionine, Radioimmunoassay and Zinc.

What This Means in Plain Language

The paper is a randomized, double-blind and crossover study of Vitamin D, K2, Magnesium and Zinc in 24 children.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 1995 (Biological trace element research), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.